https://www.selleckchem.com/pr....oducts/conteltinib-c
Introduction of new tobacco products in the United States, including those that may be lower on the risk continuum than traditional combustible cigarettes, requires premarket authorization by the US Food and Drug Administration and information on the potential impact of the products on consumer behaviors. Efficient recruitment and data capture processes are needed to collect relevant information in a near-to-real-world environment. The aim of this pilot study was to develop and test a protocol for an actual use study of a new